Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Taxotere combination therapy approved in E.U. for treatment of advanced breast cancer

Sep. 5, 2000

SuperGen updates progress of phase III rubitecan trials

Sep. 4, 2000

Arimidex approved by FDA as first-line therapy of breast cancer

Sep. 4, 2000

Cytogen and Northwest Biotherapeutics execute PSMA sublicense agreement

Sep. 4, 2000

Study results for Targretin in NSCLC support phase III program

Sep. 4, 2000

Vascular damaging agents reported by Angiogene

Sep. 1, 2000

RXR-selective ligands offer approach to tamoxifen-resistant tumors

Sep. 1, 2000

Novogen's lead anticancer compound continues to advance in clinical trials

Sep. 1, 2000

Cancer gene therapy with fusion molecule induces potent, selective apoptosis

Sep. 1, 2000

Aminobisphosphonates activate T-cells against multiple myeloma

Sep. 1, 2000

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...